Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance
Clinical trial NCT02286921 · COMPLETED
Trial details
- NCT number
- NCT02286921
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2018-10-26
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.